-+ 0.00%
-+ 0.00%
-+ 0.00%
HSS study flags calcium channel blockers as potential drug target for lumbar spinal stenosis
Share
Listen to the news
HSS study flags calcium channel blockers as potential drug target for lumbar spinal stenosis
  • HSS researchers reported Sept. 7 Cell results on a tendon-ligament stem cell tied to lumbar spinal stenosis.
  • Findings were already presented via publication, not a clinical trial readout.
  • Stenosis-linked cells appeared overactive, driving ligament thickening that can narrow the spinal canal and worsen walking-limiting symptoms.
  • Preclinical work suggested calcium channel blockers, used for hypertension, could be repurposed to curb the overgrowth.
  • Clinical studies are planned to test that approach, setting up a potential non-surgical treatment path with clear commercial repurposing implications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HSS - Hospital for Special Surgery published the original content used to generate this news brief on September 07, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending